Kathryn Edwards

Kathryn Edwards, a vaccine expert and former member of the CDC advisory panel, joins to discuss the upheaval within the CDC's vaccine advisory group and its impact on public trust. She sheds light on the controversial new appointments and their implications for vaccine safety assessments. The conversation also addresses complexities in current drug pricing policies, including the challenges pharmaceutical companies face amid government guidelines. Additionally, they explore the struggles in manufacturing mRNA-based vaccines and the shift in public health dynamics.